跳至主要内容
临床试验/NCT03284684
NCT03284684已完成不适用

Kinetics of Perioperative Circulating DNA in Cancer Surgery

Centre Hospitalier Universitaire de Nīmes3 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
3
主要终点
Change in concentration of total mutant circulating DNA

研究概览

简要总结

The aim of this study was to determine the kinetics of perioperative circulating DNA in three types of cancer. This first step will enable further studies comparing the potential impact of certain techniques or anesthetic products on cancer surgery.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The patient must have given their free and informed consent and signed the consent form
  • •The patient must be a member or beneficiary of a health insurance plan
  • •The patient is aged between 18-75
  • •Patient must weigh >40kg
  • •The patient will receive adjusted carcinological surgery
  • •Indication of curative surgery
  • •The patient has already undergone tumoral biopsy prior to surgery
  • •The patient has stage M0 cancer of either colon (right or left colonic adenocarcinoma), prostate (adenocarcinoma) or breast (infiltrating carcinoma)

排除标准

  • •The subject is in a period of exclusion determined by a previous study
  • •The patient is under safeguard of justice
  • •The subject refuses to sign the consent
  • •It is impossible to give the subject informed information
  • •The patient is pregnant, parturient or breast feeding
  • •Chronic alcoholism
  • •The patient has received radiotherapy or chemotherapy periopratively
  • •Cancer other than colon, breast or prostate
  • •The patient has currently or in the past, had a cancerous lesion
  • •Neo-adjuvant therapy (immunotherapy, radiotherapy, chemotherapy)
  • •Emergency cancer surgery

结局指标

主要结局

Change in concentration of total mutant circulating DNA

时间窗: Nine timepoints between Day-1 to Day 3

ng/mL in plasma

Change in proportion of mutant circulating DNA

时间窗: Nine timepoints between Day-1 to Day 3

ng/mL in plasma

Change in integrity index of circulating DNA for ACTB gene

时间窗: Nine timepoints between Day-1 to Day 3

concentration of long ACTB ctDNA fragments/concentration of short ACTB ctDNA fragments

Change in integrity index of circulating DNA for KRAS gene

时间窗: Nine timepoints between Day-1 to Day 3

concentration of long KRAS ctDNA fragments/concentration of short KRAS ctDNA fragments

次要结局

  • Change in plasma concentration of short (~ 145bp) fragments of KRAS gene(Nine timepoints between Day-1 to Day 3)
  • Change in plasma concentration of BRAF DNA fragments with V600E mutation(Nine timepoints between Day-1 to Day 3)
  • Change in plasma concentration of long (~ 300bp) fragments of KRAS gene(Nine timepoints between Day-1 to Day 3)
  • Change in plasma concentration of mutant KRAS DNA fragments(Nine timepoints between Day-1 to Day 3)
  • Change in plasma concentration of long (~ 290bp) fragments of ACTB gene(Nine timepoints between Day-1 to Day 3)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验